These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22090024)

  • 21. [Correction of autoimmune mechanisms underlying the development of type I diabetes mellitus by methods of cell therapy].
    Velikiĭ DA; Zakir'ianov AR; Klimenko ED; Kobozeva LP; Michunskaia AB; Pozdniakov OM
    Vestn Ross Akad Med Nauk; 2010; (9):34-42. PubMed ID: 21089446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crosstalk Between Immunity System Cells and Pancreas. Transformation of Stem Cells Used in the 3D Bioprinting Process as a Personalized Treatment Method for Type 1 Diabetes.
    Niedźwiedzka-Rystwej P; Wołącewicz M; Cywoniuk P; Klak M; Wszoła M
    Arch Immunol Ther Exp (Warsz); 2020 Apr; 68(2):13. PubMed ID: 32297019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-reactivation of neurogenin-3 and mesenchymal microenvironment is require for β-cells differentiation during fetal pancreas development and islet regeneration.
    Yang K; Wang Y; Du Z; Zhang X
    Rom J Morphol Embryol; 2014; 55(2):305-11. PubMed ID: 24969979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of Human Stem Cell-Derived Pancreatic Organoids (POs) for Regenerative Medicine.
    Navarro-Tableros V; Gomez Y; Brizzi MF; Camussi G
    Adv Exp Med Biol; 2020; 1212():179-220. PubMed ID: 31025308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming into pancreatic endocrine cells based on developmental cues.
    Kordowich S; Mansouri A; Collombat P
    Mol Cell Endocrinol; 2010 Jul; 323(1):62-9. PubMed ID: 20025937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stem-cell therapy, β-cell- and islet cell-neogenesis: possible treatments of type 1 diabetes in the future?].
    Gerő L
    Orv Hetil; 2016 May; 157(19):740-5. PubMed ID: 27133273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet Regeneration: Endogenous and Exogenous Approaches.
    Docherty FM; Sussel L
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell therapy for diabetes: stem cells, progenitors or beta-cell replication?
    Gonez LJ; Knight KR
    Mol Cell Endocrinol; 2010 Jul; 323(1):55-61. PubMed ID: 20026173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreas regeneration.
    Zhou Q; Melton DA
    Nature; 2018 May; 557(7705):351-358. PubMed ID: 29769672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
    Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
    Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing the pancreatic stem cell.
    Taylor-Fishwick DA; Pittenger GL
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):763-76. PubMed ID: 21095543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic β Cell Regeneration as a Possible Therapy for Diabetes.
    Aguayo-Mazzucato C; Bonner-Weir S
    Cell Metab; 2018 Jan; 27(1):57-67. PubMed ID: 28889951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.
    Zulewski H; Abraham EJ; Gerlach MJ; Daniel PB; Moritz W; Müller B; Vallejo M; Thomas MK; Habener JF
    Diabetes; 2001 Mar; 50(3):521-33. PubMed ID: 11246871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approaches for the cure of type 1 diabetes by cellular and gene therapy.
    Jun HS; Yoon JW
    Curr Gene Ther; 2005 Apr; 5(2):249-62. PubMed ID: 15853732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell approaches for the treatment of type 1 diabetes mellitus.
    Wagner RT; Lewis J; Cooney A; Chan L
    Transl Res; 2010 Sep; 156(3):169-79. PubMed ID: 20801414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell therapies for pancreatic beta-cell replenishment.
    Okere B; Lucaccioni L; Dominici M; Iughetti L
    Ital J Pediatr; 2016 Jul; 42(1):62. PubMed ID: 27400873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of embryonic stem cells into pancreatic beta-cell surrogates guided by ontogeny.
    Lees JG; Tuch BE
    Regen Med; 2006 May; 1(3):327-36. PubMed ID: 17465786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Regeneration of the pancreas].
    Minami K; Seino S
    Nihon Rinsho; 2008 May; 66(5):926-31. PubMed ID: 18464512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.